Aspirin-free P2Y12 inhibitor monotherapy immediately after percutaneous coronary intervention: A systematic review

Authors: Shenglong Yu, Linjuan Guo, Huizhuang Guo

Source: Heliyon, Vol 10, Iss 15, Pp e35741- (2024)

Subject Terms: Aspirin-free strategy, P2Y12 inhibitor monotherapy, Dual antiplatelet therapy, Percutaneous coronary intervention, Outcomes, Science (General), Q1-390, Social sciences (General), H1-99

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844024117720; https://doaj.org/toc/2405-8440

Access URL: https://doaj.org/article/d42c3eaf32614b4284847d56dc754490

P2y12 inhibitor monotherapy after 1–3 months dual antiplatelet therapy in patients with coronary artery disease and chronic kidney disease undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Authors: Yanqiao Yu, Deng Pan, Ruina Bai, Jinwen Luo, Yu Tan, Wenhui Duan, Dazhuo Shi

Source: Frontiers in Cardiovascular Medicine, Vol 10 (2023)

Subject Terms: P2Y12 inhibitor monotherapy, dual antiplatelet therapy, chronic kidney disease, coronary artery disease, meta-analysis, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcvm.2023.1197161/full; https://doaj.org/toc/2297-055X

Access URL: https://doaj.org/article/2246a6c167fc4103ba80f5e32b531434

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

Authors: Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, Dik Heg, Kurt Schmidlin, Christian Hamm, Philippe Gabriel Steg, Giuseppe Gargiulo, Eugene P. McFadden, Yoshinobu Onuma, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Sergio Leonardi, Aleksander Zurakowski, Alessio Arrivi, Robert Jan Van Geuns, Kurt Huber, Ton Slagboom, Paolo Calabrò, Patrick W. Serruys, Peter Jüni, Marco Valgimigli, Stephan Windecker

Source: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 10 (2022)

Subject Terms: DAPT, intention‐to‐treat, P2Y12 inhibitor monotherapy, per‐protocol, ticagrelor, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/2047-9980

Access URL: https://doaj.org/article/21f479071bb14de085c6f9d4556ce456

Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy

Authors: Sheng-Wei Huang, Po-Wei Chen, Wen-Han Feng, I-Chang Hsieh, Ming-Yun Ho, Chung-Wei Cheng, Hung-I Yeh, Ching-Pei Chen, Wei-Chun Huang, Ching-Chang Fang, Hui-Wen Lin, Sheng-Hsiang Lin, Chin-Feng Tsai, Chun-Hung Su, Yi-Heng Li

Source: Frontiers in Cardiovascular Medicine, Vol 8 (2022)

Subject Terms: P2Y12 inhibitor, acute coronary syndrome, DAPT score, P2Y12 inhibitor monotherapy, clinical outcome, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcvm.2021.772820/full; https://doaj.org/toc/2297-055X

Access URL: https://doaj.org/article/b1de4c30a3c245c99329948fa18aae39

P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis

Authors: Wen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, Hsiao-Ling Chen, Chun-Yin Chen, Tsung-Han Lin, Tzu-Chieh Lin, Ching-Tang Chang, Hsuan-Fu Kuo, Hsiu-Mei Chang, Chih-Sheng Chu

Source: Pharmaceuticals, Vol 16, Iss 2, p 232 (2023)

Subject Terms: P2Y12 inhibitor monotherapy, percutaneous coronary intervention (PCI), acute coronary syndrome (ACS), Medicine, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1424-8247/16/2/232; https://doaj.org/toc/1424-8247

Access URL: https://doaj.org/article/20e4e9e5d2fc40fb958f0683dc6780d1